AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Improving Our Understanding of Respiratory Muscle Training to Facilitate Weaning From Mechanical Ventilation in the ICU

RecruitingNAAges 18 Years - anyAllKU Leuven
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Mechanical ventilation is a life-saving treatment frequently applied in intensive care unit (ICU). Nonetheless, by putting at rest the respiratory muscles, it can lead to respiratory muscle weakness and atrophy, which are accompanied by prolonged duration of mechanical ventilation, difficult weaning and increased ICU mortality. Despite a strong theoretical rationale and some evidence supporting the use of inspiratory muscle training (IMT) to address respiratory muscle weakness and atrophy, the optimal approach to IMT remains largely uncertain. In fact, mechanistic studies evaluating physiological adaptations that occur in respiratory muscles of mechanically ventilated patients in response to different training regimens have not been conducted so far. The aim of this study is to comprehensively investigate changes in respiratory muscle function in response to three different conditions t

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Difficult and prolonged weaning patients * Adequate oxygenation * Febrile temperature \< 38ยบC * Hemodynamic stability * Stable blood pressure * No or minimal vasopressors * No myocardial ischemia * Adequate hemoglobin and mentation * Resolution of disease acute phase * Able to follow simple verbal commands related to IMT * Mechanically ventilated via a tracheostomy or endotracheal tube Exclusion Criteria: * Pre-existing neuromuscular disease * Agitation * Hemodynamically instable (arrhythmia, decompensated heart failure, coronary insufficiency) * Hemoptysis * Diaphoresis * Spinal cord injury above T8 * Use of any type of home MV support prior to hospitalization * Skeletal pathology that impairs chest wall movements * Poor general prognosis or fatal outcome
๐Ÿ’Š

What it tests

  • Procedure: Usual Care (UC)
  • Procedure: UC + HI-IMT
  • Procedure: UC + LI-IMT (sham IMT)
๐Ÿ“

Where

1 site
University Hospital Leuven
Leuven, Belgium
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy